Unicycive Therapeutics logo

Unicycive Therapeutics Share Price Today

(NASDAQ: UNCY)

Unicycive Therapeutics share price is $0.62 & ₹52.60 as on 8 May 2025, 2.30 'hrs' IST

$0.62

0.02

(3.19%)

Market is closed - opens 7 PM, 08 May 2025

View live Unicycive Therapeutics share price in Dollar and Rupees. Guide to invest in Unicycive Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Unicycive Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Unicycive Therapeutics share price movements

  • Today's Low: $0.62
    Today's High: $0.63

    Day's Volatility :2.69%

  • 52 Weeks Low: $0.20
    52 Weeks High: $1.20

    52 Weeks Volatility :83.17%

Unicycive Therapeutics (UNCY) Returns

PeriodUnicycive Therapeutics IncIndex (Russel 2000)
3 Months
0.33%
0.0%
6 Months
7.23%
0.0%
1 Year
-45.93%
0.0%
3 Years
-23.63%
-3.8%

Unicycive Therapeutics (UNCY) Key Statistics

in dollars & INR

Previous Close
$0.6055
Open
$0.6301
Today's High
$0.6321
Today's Low
$0.6151
Market Capitalization
$78.1M
Today's Volume
$813.0K
52 Week High
$1.2
52 Week Low
$0.202
Revenue TTM
$0.0
EBITDA
$-32.1M
Earnings Per Share (EPS)
$-0.56
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-2028.11%

How to invest in Unicycive Therapeutics Stock (UNCY) from India?

It is very easy for Indian residents to invest directly in Unicycive Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Unicycive Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Unicycive Therapeutics or UNCY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Unicycive Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Unicycive Therapeutics shares which would translate to 1.368 fractional shares of Unicycive Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Unicycive Therapeutics, in just a few clicks!

Returns in Unicycive Therapeutics (UNCY) for Indian investors in Rupees

The Unicycive Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Unicycive Therapeutics investment value today

Current value as on today

₹56,490

Returns

₹43,510

(-43.51%)

Returns from Unicycive Therapeutics Stock

₹45,133 (-45.13%)

Dollar Returns

₹1,623 (+1.62%)

Indian investors sentiment towards Unicycive Therapeutics (UNCY)

-55%

Period: Apr 7, 2025 to May 7, 2025. Change in 30 Days versus previous period

Search interest for Unicycive Therapeutics Stock from India on INDmoney has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Unicycive Therapeutics

  • Great Point Partners LLC

    9.17%

  • Nantahala Capital Management, LLC

    8.68%

  • Octagon Capital Advisors LP

    8.35%

  • Vivo Capital, LLC

    8.33%

  • Logos Global Management LP

    4.24%

  • Walleye Trading Advisors, LLC

    4.18%

Analyst Recommendation on Unicycive Therapeutics

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Unicycive Therapeutics(by analysts ranked 0 to 5 stars)

Analyst Forecast on Unicycive Therapeutics Stock (UNCY)

What analysts predicted

Upside of 902.31%

Target:

$6.21

Current:

$0.62

Insights on Unicycive Therapeutics Stock (Ticker Symbol: UNCY)

  • Price Movement

    In the last 7 days, UNCY stock has moved down by -6.0%
  • Decreasing Revenue

    Revenue is down for the last 3 quarters, 951.0K → -271.0K (in $), with an average decrease of 84.6% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, 3.93M → -21.52M (in $), with an average decrease of 314.9% per quarter
  • UNCY vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 77.3% return, outperforming this stock by 123.2%
  • UNCY vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 100.4% return, outperforming this stock by 129.1%

Unicycive Therapeutics Technicals Summary

Sell

Neutral

Buy

Unicycive Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Unicycive Therapeutics (UNCY) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Unicycive Therapeutics Inc logo
29.97%
7.23%
-45.93%
-23.63%
-89.56%
Regeneron Pharmaceuticals, Inc. logo
0.42%
-32.18%
-41.5%
-6.77%
-2.61%
Beone Medicines Ltd logo
15.33%
16.77%
46.87%
79.94%
47.93%
Vertex Pharmaceuticals Incorporated logo
-4.56%
-10.27%
7.65%
91.83%
58.03%
Alnylam Pharmaceuticals, Inc. logo
20.39%
-0.79%
77.34%
120.43%
89.62%

About Unicycive Therapeutics

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also evaluates licensing of technologies and drugs for orphan diseases, other renal, liver, and other metabolic diseases affecting fibrosis and inflammation. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd to develop and commercialize oxylanthanum carbonate; Sphaera Pharma Pte. Ltd.; Syneos Health LLC to develop of UNI-494; Inotiv for preclinical trial and related services for oxylanthanum carbonate and UNI-494; Lee's Pharmaceutical (HK) Limited; and Lotus International Pte Ltd for the development, registration filing, and approval for oxylanthanum carbonate. The company was incorporated in 2016 and is based in Los Altos, California.
Organization
Unicycive Therapeutics
Employees
22
CEO
Dr. Shalabh K. Gupta M.D., MPA
Industry
Miscellaneous

Management People of Unicycive Therapeutics

NameTitle
Dr. Shalabh K. Gupta M.D., MPA
Founder, Chairman, CEO & President
Dr. Pramod Gupta Ph.D.
Executive Vice President of Pharmaceutical & Business Operations
Mr. Douglas Jermasek M.B.A.
Executive Vice President of Corporate Strategy

Important FAQs about investing in UNCY Stock from India :

What is Unicycive Therapeutics share price today?

Unicycive Therapeutics share price today stands at $0.62, Open: $0.63 ; Previous Close: $0.61 ; High: $0.63 ; Low: $0.62 ; 52 Week High: $1.20 ; 52 Week Low: $0.20.

The stock opens at $0.63, after a previous close of $0.61. The stock reached a daily high of $0.63 and a low of $0.62, with a 52-week high of $1.20 and a 52-week low of $0.20.

Can Indians buy Unicycive Therapeutics shares?

Yes, Indians can invest in the Unicycive Therapeutics (UNCY) from India.

With INDmoney, you can buy Unicycive Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Unicycive Therapeutics at zero transaction cost.

How can I buy Unicycive Therapeutics shares from India?

It is very easy to buy Unicycive Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Unicycive Therapeutics (UNCY) be purchased?

Yes, you can buy fractional shares of Unicycive Therapeutics with INDmoney app.

What are the documents required to start investing in Unicycive Therapeutics stocks?

To start investing in Unicycive Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Unicycive Therapeutics Stock (UNCY)?

Today’s highest price of Unicycive Therapeutics (UNCY) is $0.63.

Today’s lowest price of Unicycive Therapeutics (UNCY) is $0.62.

What is today's market capitalisation of Unicycive Therapeutics?

Today's market capitalisation of Unicycive Therapeutics UNCY is 78.1M

What is the 52 Week High and Low Range of Unicycive Therapeutics Stock (UNCY)?

  • 52 Week High

    $1.20

  • 52 Week Low

    $0.20

What are the historical returns of Unicycive Therapeutics (UNCY)?

  • 1 Month Returns

    29.97%

  • 3 Months Returns

    7.23%

  • 1 Year Returns

    -45.93%

  • 5 Years Returns

    -89.56%

Who is the Chief Executive Officer (CEO) of Unicycive Therapeutics ?

Dr. Shalabh K. Gupta M.D., MPA is the current Chief Executive Officer (CEO) of Unicycive Therapeutics.